{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T22:45:40Z","timestamp":1772577940556,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"am","delay-in-days":382,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.pan.2020.12.002","type":"journal-article","created":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T02:11:31Z","timestamp":1607307091000},"page":"236-239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Total gastrectomy for severe proton pump inhibitor-induced hypomagnesemia in a MEN1\/Zollinger Ellison syndrome patient"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4528-5471","authenticated-orcid":false,"given":"Marine","family":"Perrier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Delemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Deguelte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2701-0888","authenticated-orcid":false,"given":"Vincent","family":"Legros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8155-7710","authenticated-orcid":false,"given":"Hedia","family":"Brixi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Kianmanesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Cadiot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pan.2020.12.002_bib1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000335591","article-title":"ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes","volume":"95","author":"Jensen","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pan.2020.12.002_bib2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00006676-199305000-00003","article-title":"Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type I multiple endocrine neoplasia","volume":"8","author":"Ruszniewski","year":"1993","journal-title":"Pancreas"},{"key":"10.1016\/j.pan.2020.12.002_bib3","first-page":"4673","article-title":"Surgical management of Zollinger-Ellison syndrome: classical considerations and current controversies","volume":"25","author":"Shao","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.pan.2020.12.002_bib4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cgh.2011.08.012","article-title":"The Zollinger-Ellison syndrome: dangers and consequences of interrupting antisecretory treatment","volume":"10","author":"Poitras","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.pan.2020.12.002_bib5","doi-asserted-by":"crossref","first-page":"668","DOI":"10.7326\/0003-4819-87-6-668","article-title":"H2-Histamine receptor blocking agents in the Zollinger-Ellison syndrome. Experience in seven cases and implications for long-term therapy","volume":"87","author":"McCarthy","year":"1977","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pan.2020.12.002_bib6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11894-009-0067-6","article-title":"Gastric acid hypersecretory states: recent insights and advances","volume":"11","author":"Osefo","year":"2009","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.pan.2020.12.002_bib7","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.3748\/wjg.v18.i39.5495","article-title":"Diagnosis of Zollinger-Ellison syndrome: increasingly difficult","volume":"18","author":"Ito","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.pan.2020.12.002_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20205128","article-title":"Insights into effects\/risks of chronic hypergastrinemia and lifelong PPI treatment in man based on studies of patients with zollinger-ellison syndrome","volume":"20","author":"Lee","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pan.2020.12.002_bib9","first-page":"19","article-title":"Review of the long-term effects of proton pump inhibitors","volume":"34","author":"Lehault","year":"2017","journal-title":"Fed Pract"},{"key":"10.1016\/j.pan.2020.12.002_bib10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.mayocp.2017.10.022","article-title":"Proton pump inhibitors: review of emerging concerns","volume":"93","author":"Nehra","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.pan.2020.12.002_bib11","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMc066308","article-title":"Proton-pump inhibitors and hypomagnesemic hypoparathyroidism","volume":"355","author":"Epstein","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pan.2020.12.002_bib12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/MOG.0b013e32833ff5d6","article-title":"Proton pump inhibitors and severe hypomagnesaemia","volume":"27","author":"Cundy","year":"2011","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.pan.2020.12.002_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112558","article-title":"The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis","volume":"9","author":"Park","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.pan.2020.12.002_bib14","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1053\/j.ajkd.2015.05.012","article-title":"Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study","volume":"66","author":"Kieboom","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.pan.2020.12.002_bib15","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015011","article-title":"Does the use of proton pump inhibitors increase the risk of hypomagnesemia: an updated systematic review and meta-analysis","volume":"98","author":"Liao","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.pan.2020.12.002_bib16","series-title":"FDA Drug Safety Communication: low magnesium levels can be associated with long-term use of Proton Pump Inhibitor drugs (PPIs)","author":"Research C for","year":"2018"},{"key":"10.1016\/j.pan.2020.12.002_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-205165","article-title":"From hypomagnesaemia to Zollinger-Ellison syndrome: an adverse effect of a proton pump inhibitor","volume":"2014","author":"Eyal","year":"2014","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.pan.2020.12.002_bib18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1179\/0001551213Z.0000000008","article-title":"Severe symptomatic hypomagnesaemia induced by the chronic use of proton pump inhibitors: a case report of a patient with Zollinger-Ellison syndrome","volume":"69","author":"Str\u00f6ker","year":"2014","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.pan.2020.12.002_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2217\/ije-2017-0018","article-title":"Diagnosis of Zollinger-Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing","volume":"4","author":"Metz","year":"2017","journal-title":"Int J Endocr Oncol"},{"key":"10.1016\/j.pan.2020.12.002_bib20","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1210\/jc.2002-021314","article-title":"Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1","volume":"88","author":"Gibril","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.pan.2020.12.002_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/MD.0b013e3182954af1","article-title":"Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1\/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors","volume":"92","author":"Ito","year":"2013","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.pan.2020.12.002_bib22","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1345\/aph.1R556","article-title":"Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?","volume":"47","author":"Luk","year":"2013","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.pan.2020.12.002_bib23","doi-asserted-by":"crossref","first-page":"152","DOI":"10.5527\/wjn.v5.i2.152","article-title":"Proton-pump inhibitor-induced hypomagnesemia: current research and proposed mechanisms","volume":"5","author":"William","year":"2016","journal-title":"World J Nephrol"},{"key":"10.1016\/j.pan.2020.12.002_bib24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/FPC.0000000000000259","article-title":"Common single nucleotide polymorphisms in transient receptor potential melastatin type 6 increase the risk for proton pump inhibitor-induced hypomagnesemia: a case-control study","volume":"27","author":"Hess","year":"2017","journal-title":"Pharmacogenetics Genom"},{"key":"10.1016\/j.pan.2020.12.002_bib25","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1111\/jgh.14141","article-title":"Proton pump inhibitors not associated with hypomagnesemia, regardless of dose or concomitant diuretic use","volume":"33","author":"Chowdhry","year":"2018","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.pan.2020.12.002_bib26","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2165\/00002018-200528090-00003","article-title":"Drug-induced hypomagnesaemia\u00a0: scope and management","volume":"28","author":"Atsmon","year":"2005","journal-title":"Drug Saf"},{"key":"10.1016\/j.pan.2020.12.002_bib27","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/01.sla.0000143252.02142.3e","article-title":"Resolved and unresolved controversies in the surgical management of patients with zollinger-ellison syndrome","volume":"240","author":"Norton","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.pan.2020.12.002_bib28","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ecl.2018.04.009","article-title":"Gastrinomas: medical or surgical treatment","volume":"47","author":"Norton","year":"2018","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.pan.2020.12.002_bib29","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/01.sla.0000189549.51913.d8","article-title":"Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1","volume":"242","author":"Bartsch","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.pan.2020.12.002_bib30","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00423-011-0828-1","article-title":"Long-term results of surgery for pancreatic neuroendocrine neoplasms in patients with MEN1","volume":"396","author":"Lopez","year":"2011","journal-title":"Langenbeck\u2019s Arch Surg"},{"key":"10.1016\/j.pan.2020.12.002_bib31","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3748\/wjg.v17.i10.1343","article-title":"Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients","volume":"17","author":"Imamura","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.pan.2020.12.002_bib32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/01.sla.0000218073.77254.62","article-title":"Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias","volume":"244","author":"Tonelli","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.pan.2020.12.002_bib33","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00268-015-3328-6","article-title":"Postoperative complications, in-hospital mortality and 5-year survival after surgical resection for patients with a pancreatic neuroendocrine tumor: a systematic review","volume":"40","author":"Jilesen","year":"2016","journal-title":"World J Surg"},{"key":"10.1016\/j.pan.2020.12.002_bib34","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/SLA.0b013e3182536339","article-title":"Partial pancreaticoduodenectomy can provide cure for duodenal gastrinoma associated with multiple endocrine neoplasia type 1","volume":"257","author":"Lopez","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.pan.2020.12.002_bib35","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0016-5085(92)90157-T","article-title":"Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome","volume":"102","author":"Pisegna","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pan.2020.12.002_bib36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10620-010-1234-1","article-title":"Mechanism of acid hypersecretion post curative gastrinoma resection","volume":"56","author":"Ojeaburu","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.pan.2020.12.002_bib37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00006676-198804000-00006","article-title":"Long-acting somatostatin (SMS 201-995) in the management of Zollinger-Ellison syndrome: evidence for sustained efficacy","volume":"3","author":"Ruszniewski","year":"1988","journal-title":"Pancreas"},{"key":"10.1016\/j.pan.2020.12.002_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051682","article-title":"Somatostatin analogs in clinical practice: a review","volume":"21","author":"Gomes-Porras","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pan.2020.12.002_bib39","first-page":"58","article-title":"Is total gastrectomy still a viable option in the management of patients with the Zollinger-Ellison syndrome?","volume":"45","author":"Franz","year":"2007","journal-title":"S\u00a0Afr J Surg"},{"key":"10.1016\/j.pan.2020.12.002_bib40","series-title":"Insulinomas and other tumours","first-page":"13171324","author":"Rattner","year":"1994"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390320308620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390320308620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T16:13:48Z","timestamp":1761408828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390320308620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1424390320308620"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2020.12.002","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Total gastrectomy for severe proton pump inhibitor-induced hypomagnesemia in a MEN1\/Zollinger Ellison syndrome patient","name":"articletitle","label":"Article Title"},{"value":"Pancreatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pan.2020.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 IAP and EPC. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}